Nebraska Cancer Specialists

Summary

Nebraska Cancer Specialists is a medical facility located in Grand Island, Nebraska. This center is recognized for care of Breast Cancer, Chronic Lymphocytic Leukemia, MALT Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma and other specialties. Nebraska Cancer Specialists is involved with conducting 7 clinical trials across 30 conditions. There are 3 research doctors associated with this hospital, such as Ralph Hauke, MD, Margaret Block, M.D., and David Crockett, MD.

Top PIs

Clinical Trials running at Nebraska Cancer Specialists

Follicular Lymphoma

Marginal Zone Lymphoma

MALT Lymphoma

Breast Cancer

Chronic Lymphocytic Leukemia

Non-Hodgkin's Lymphoma

Mantle Cell Lymphoma

Small Cell Lung Cancer

Mixed-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

Zanubrutinib + Anti-CD20

for Lymphoma

The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R\^2) in participants with relapsed/refractory (R/R) follicular lymphoma (FL), as measured by progression-free survival as determined by an independent review committee in accordance with the 2014 modification of the International Working Group on non-Hodgkin lymphoma (NHL) Criteria based on n positron emission tomography and computed tomography (PET/CT), and to compare the efficacy of zanubrutinib plus rituximab versus R\^2 in participants with R/R marginal zone lymphoma (MZL), as measured by progression free survival (PFS) assessed by IRC in accordance with CT-based Lugano 2014 Criteria.

Recruiting

2 awards

Phase 3

5 criteria

BGB-16673

for B-Cell Cancers

This trial tests a new drug called BGB-16673 to find the best dose for patients. It aims to determine how well the drug works and its safety. The study involves finding the right dose and expanding testing to more patients.

Recruiting

1 award

Phase 1 & 2

5 criteria